Hikma Pharmaceuticals PLC (OTCMKTS:HKMPY) Sees Significant Increase in Short Interest

Hikma Pharmaceuticals PLC (OTCMKTS:HKMPY) was the target of a significant growth in short interest in September. As of September 30th, there was short interest totaling 454 shares. Based on an average daily trading volume, of 422 shares, the days-to-cover ratio is presently 1.1 days.

Hikma Pharmaceuticals Price Performance

Hikma Pharmaceuticals stock remained flat at $42.03 during mid-day trading on Wednesday. The company’s stock had a trading volume of 349 shares, compared to its average volume of 1,255. The firm’s 50 day simple moving average is $43.31 and its two-hundred day simple moving average is $40.64. Hikma Pharmaceuticals has a 12-month low of $31.80 and a 12-month high of $49.31.

Hikma Pharmaceuticals Company Profile

Hikma Pharmaceuticals PLC is a global pharmaceutical company headquartered in London, United Kingdom. Founded in 1978 by Samih Darwazah in Jordan, the company develops, manufactures and markets a broad range of prescription medicines for healthcare providers and patients.

Hikma operates through three principal businesses: Injectables, Generics and Branded Medicines. Its portfolio includes hospital injectable products, specialty and generic medicines, and branded pharmaceutical products in areas such as respiratory care, cardiovascular treatment, pain management, anti-infectives and central nervous system therapies.